stella
beta
Interventional Left Ventricular Assist System for PCI in CHIP Patients — Stella
Home
/
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
/
View on ClinicalTrials.gov
Recruiting
Back to High-Risk Percutaneous Coronary Intervention (High-risk PCI) trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(15 sites)
China
Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality
Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Fujian
The First Hospital of Lanzhou University, Lanzhou, Gansu
Guangdong Provincial People's Hospital, Guangzhou, Guangdong
Nanfang Hospital Southern Medical University, Guangzhou, Guangdong
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
People's Hospital of Hunan Province, Changsha, Hunan
Suzhou Municipal Hospital, Suzhou, Jiangsu
Jiangxi Provincial People's Hospital, Nanchang, Jiangxi
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
The People's Hospital of Liaoning Province, Shenyang, Liaining
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang
Zhejiang Hospital, Hangzhou, Zhejiang
The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang